TGFB1 and neoplasm: Notably, high TGFβ expression and signaling is associated with poor prognosis in multiple cancer types (52, 70) because TGFβ becomes a tumor promoter that is involved in tumor progression by modifying the TME, suppressing immune response, and promoting metastasis (71).